Hikma Ventures

About The Fund

Hikma Ventures is the corporate venture arm of Hikma Pharmaceuticals, primarily focused on empowering the future of healthcare by investing in global emerging companies within the digital health sector. Founded in 2015 with offices in London, United Kingdom, and an additional presence in Amman, Jordan, the fund seeks to bring innovative solutions to the healthcare market. Their investment activities range from Seed to Later Stage ventures, including startups, early-stage firms, companies in the expansion phase, and spinout or merging businesses. With a comprehensive investment range, they offer minimum funding of $10,000,000 and can invest up to $47,600,000, emphasizing their ability to support growth at various levels. The industries they target include HealthTech, Fitness, and Medical Devices, with hospital services playing a critical role in their portfolio. Hikma Ventures operates as a Corporate Venture Capital (CVC) firm, leveraging the extensive pharmaceutical expertise of its parent organization, Hikma Pharmaceuticals, to offer more than just capital. Their specialist approach allows them to provide value-added support to portfolio companies, assisting in navigating the complex landscape of healthcare regulations, product development, and market dynamics. This hands-on guidance is driven by their equity expertise, making them a vital partner for healthcare innovators seeking financial investment and strategic mentorship. Through their investments, they aim to contribute to the delivery of better health outcomes and to drive the transformation in healthcare through technology and innovation.